These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6644545)

  • 41. Suppositories containing beta-cyclodextrin complexes. Part 1: Stability studies.
    Szente L; Apostol I; Szejtli J
    Pharmazie; 1984 Oct; 39(10):697-9. PubMed ID: 6522449
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cyclodextrin-stabilized volatile substances for inhalation therapy.
    Gál-Füzy M; Szente L; Szejtli J; Harangi J
    Pharmazie; 1984 Aug; 39(8):558-9. PubMed ID: 6504980
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyclodextrin polymer, a new tablet disintegrating agent.
    Fenyvest E; Antal B; Zsadon B; Szejtli J
    Pharmazie; 1984 Jul; 39(7):473-5. PubMed ID: 6494226
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The investigation of cyclodextrin polymer as a new disintegrant for direct compressed tablets.
    Sekulović D; Zajić L
    Pharmazie; 1987 Aug; 42(8):556. PubMed ID: 3432343
    [No Abstract]   [Full Text] [Related]  

  • 45. Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes.
    Loftsson T; Brewster ME
    J Pharm Pharmacol; 2011 Sep; 63(9):1119-35. PubMed ID: 21827484
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Production and investigating of tablets containing furosemide and beta-cyclodextrin.
    Kata M; Haragh L; Pintye-Hódi K
    Acta Pharm Hung; 1990 Jan; 60(1):40-5. PubMed ID: 2327256
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preparation of a phenytoin beta-cyclodextrin complex and evaluation of a suspension and a tablet dosage form prepared from the complex.
    Hegde RP; Rhodes CT
    Pharm Acta Helv; 1985; 60(2):53-7. PubMed ID: 3991746
    [No Abstract]   [Full Text] [Related]  

  • 48. Enhancement of solubility of furosemide with beta-cyclodextrin.
    Kata M; Antal A
    Pharmazie; 1984 Dec; 39(12):856-7. PubMed ID: 6531396
    [No Abstract]   [Full Text] [Related]  

  • 49. [Stability test of chloramphenicol-beta-cyclodextrin-containing tablets].
    Szabó-Révész P; Pintye-Hódi K; Miseta M; Selmeczi B
    Pharmazie; 1988 Aug; 43(8):554-5. PubMed ID: 3237749
    [No Abstract]   [Full Text] [Related]  

  • 50. Improvement of some pharmaceutical properties of drugs by cyclodextrin complexation. Part 6: Ampicillin.
    Ammar HO; el-Nahhas SA; Ghorab MM
    Pharmazie; 1996 Aug; 51(8):568-70. PubMed ID: 8794467
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Studies on cyclodextrin polymer. Part 1: The effect of CDP on indomethacin tablet formulation.
    Tarimci N; Celebi N
    Pharmazie; 1988 May; 43(5):323-5. PubMed ID: 3174808
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monitoring by headspace gaschromatography (HSGC) of formation and thermal stability of terpene beta-cyclodextrin complexes.
    Vincieri FF; Mazzi G; Papini P; Gelsomini N
    Farmaco Prat; 1986 Mar; 41(3):98-106. PubMed ID: 3709770
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparative study on inclusion complexation of beta-cyclodextrin and tri-O-methyl-beta-cyclodextrin with several drugs in aqueous solution.
    Otagiri M; Uekama K; Imai T; Maeda T; Takadate A; Goya S; Janssen LH
    Acta Pharm Suec; 1984; 21(6):357-66. PubMed ID: 6534072
    [No Abstract]   [Full Text] [Related]  

  • 54. Efficacy and Safety Profile of Diclofenac/Cyclodextrin and Progesterone/Cyclodextrin Formulations: A Review of the Literature Data.
    Scavone C; Bonagura AC; Fiorentino S; Cimmaruta D; Cenami R; Torella M; Fossati T; Rossi F
    Drugs R D; 2016 Jun; 16(2):129-40. PubMed ID: 26939533
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Studies of cyclodextrin inclusion complexes: II--Inclusion complexes between alpha-cyclodextrin and N-desmethyldiazepam and chlordiazepoxide.
    Aboutaleb AE; Abdel Rahman A; Samy EM
    J Pharm Belg; 1988; 43(6):437-44. PubMed ID: 3150006
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of hydroxypropyl beta cyclodextrin complexation on aqueous solubility, stability, and corneal permeation of acyl ester prodrugs of ganciclovir.
    Tirucherai GS; Mitra AK
    AAPS PharmSciTech; 2003; 4(3):E45. PubMed ID: 14621977
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alleviation of prochlorperazine-induced primary irritation of skin by cyclodextrin complexation.
    Uekama K; Irie T; Sunada M; Otagiri M; Arimatsu Y; Nomura S
    Chem Pharm Bull (Tokyo); 1982 Oct; 30(10):3860-2. PubMed ID: 7160028
    [No Abstract]   [Full Text] [Related]  

  • 58. Cyclodextrins: their future in drug formulation and delivery.
    Stella VJ; Rajewski RA
    Pharm Res; 1997 May; 14(5):556-67. PubMed ID: 9165524
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Improvement in pharmacological properties of thiopental by gamma-cyclodextrin complexation].
    Arimori K; Iwaoku R; Nakano M; Uemura Y; Otagiri M; Uekama K
    Yakugaku Zasshi; 1983 May; 103(5):553-8. PubMed ID: 6644545
    [No Abstract]   [Full Text] [Related]  

  • 60. Enhanced oral bioavailability of antiinflammatory drug flurbiprofen in rabbits by tri-O-methyl-beta-cyclodextrin complexation.
    Otagiri M; Imai T; Uekama K
    J Pharmacobiodyn; 1982 Dec; 5(12):1027-9. PubMed ID: 7169606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.